Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2024 Aug 23:104:adv40929.
doi: 10.2340/actadv.v104.40929.

Evaluating the Frequency of Mole Checks by a Dermatologist and Correlated Variables in a Global Survey across 17 Countries: HELIOS Project

Affiliations
Multicenter Study

Evaluating the Frequency of Mole Checks by a Dermatologist and Correlated Variables in a Global Survey across 17 Countries: HELIOS Project

Henry William Lim et al. Acta Derm Venereol. .

Abstract

Secondary prevention of skin cancer consists in early detection of malignant lesions through patients' mole self-examination and medical examination. The objective of this study was to assess the self-reported frequency of mole examination in a large, representative sample of the adult general population of 17 countries from all continents. Of a total of 17,001 participants, 4.8% had their moles checked by a dermatologist more than once a year, 11.3% once a year, 8.4% every 2-3 years, 12.4% once in a while, 10.3% once in lifetime, and 52.6% of participants had never performed a mole examination. Egypt was the country with the highest prevalence of people who performed a moles check more than once a year (15.9%), followed by Brazil and the USA. A higher frequency of mole checks was associated with sex (man vs woman), higher education, higher income, fair phototype, history of skin cancer, medical insurance, and sun-protective behaviours. Despite recommendations by health providers, it appears that the frequency of mole checks in the general population is still low. It is necessary for dermatologists to keep informing at-risk populations about the importance of moles check, with particular care regarding categories that less frequently adhere to secondary prevention measures.

PubMed Disclaimer

Conflict of interest statement

HWL is an investigator for L’Oréal, has served as a consultant for La Roche-Posay, and has been a speaker on a general educational session for La Roche-Posay. TP reports personal fees from La Roche Posay during the conduct of the study and personal fees from L’Oréal. CLG reports receiving honorarium from La Roche-Posay, Galderma, and Cantabria Lab. HYK reports personal fees from L’Oréal during the conduct of the study. AM reports personal fees from L’Oréal during the conduct of the study. JO-C reports personal fees from La Roche Posay during the conduct of the study. SP reports personal fees from La Roche Posay during the conduct of the study and personal fees and non-financial support from La Roche Posay. SS has served as a consultant for La Roche Posay and has participated as a speaker in an educational session for La Roche-Posay. LW reports personal fees from La Roche Posay during the conduct of the study. ALD, CLF, and DK are employees of La Roche Posay. JK reports personal fees from La Roche Posay during the conduct of the study and grants and personal fees from L’Oréal. FL and BD have nothing to disclose.

Similar articles

Cited by

References

    1. Zhang W, Zeng W, Jiang A, He Z, Shen X, Dong X, et al. Global, regional and national incidence, mortality and disability-adjusted life-years of skin cancers and trend analysis from 1990 to 2019: an analysis of the Global Burden of Disease Study 2019. Cancer Med 2021; 10: 4905–4922. 10.1002/cam4.4046 - DOI - PMC - PubMed
    1. Urban K, Mehrmal S, Uppal P, Giesey RL, Delost GR. The global burden of skin cancer: a longitudinal analysis from the Global Burden of Disease Study, 1990–2017. JAAD Int 2021; 2: 98-108. 10.1016/j.jdin.2020.10.013 - DOI - PMC - PubMed
    1. Perez M, Abisaad JA, Rojas KD, Marchetti MA, Jaimes N. Skin cancer: primary, secondary, and tertiary prevention. Part I. J Am Acad Dermatol 2022; 87: 255–268. 10.1016/j.jaad.2021.12.066 - DOI - PubMed
    1. Rojas KD, Perez ME, Marchetti MA, Nichols AJ, Penedo FJ, Jaimes N. Skin cancer: primary, secondary, and tertiary prevention. Part II. J Am Acad Dermatol 2022; 87: 271–288. 10.1016/j.jaad.2022.01.053 - DOI - PubMed
    1. Datzmann T, Schoffer O, Meier F, Seidler A, Schmitt J. Are patients benefiting from participation in the German skin cancer screening programme? A large cohort study based on administrative data. Br J Dermatol 2022; 186: 69–77. 10.1111/bjd.20658 - DOI - PubMed

Publication types

MeSH terms

LinkOut - more resources